SKI Market

A+| A| A-|

Indian Indices

Sensex

74,563.92 -1,470.50
( -1.93%)

Global Indices

Nasdaq

46,702.98 -735.30
(-1.55%)

Dow Jones

6,694.68 -102.12
(-1.50%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,300.41 -53.36
(-0.52%)

Forex

USD-INR

91.92 0.02
(0.02%)

EUR-INR

106.58 -0.28
(-0.27%)

GBP-INR

123.39 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5573934

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

23.72

110068.55

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.61

Back

Welspun Specialty Solutions reports standalone net profit of Rs 9.51 crore in the December 2025 quarter

Jan 23,2026

Net profit of Welspun Specialty Solutions reported to Rs 9.51 crore in the quarter ended December 2025 as against net loss of Rs 3.60 crore during the previous quarter ended December 2024. Sales rose 16.49% to Rs 226.05 crore in the quarter ended December 2025 as against Rs 194.05 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	226.05	194.05	16
OPM %	7.50	3.84	-
PBDT	13.87	0.61	2174
PBT	9.51	-3.60	LP
NP	9.51	-3.60	LP

74,563.92 -1,470.50 ( -1.93%)

46,702.98 -735.30 (-1.55%)

6,694.68 -102.12 (-1.50%)

53,838.16 -614.80 (-1.13%)

10,300.41 -53.36 (-0.52%)

91.92 0.02 (0.02%)

106.58 -0.28 (-0.27%)

123.39 -0.12 (-0.10%)

0.58 0.00 (-0.46%)